Evidence map›Paper›PMID 41366489›Full record

ArticleActa neuropathologica communications2025

Seizure occurrence in FCD type II is predicted by lesion position and linked to cytoarchitectural alterations.

Natálie Procházková, Carl Václav Lím Olson, Niki Shariati, Jana Thao Rozlivková, Jana Populová, Monika Řehořová, Jan Kudláček, Přemysl Jiruška, Ondřej Novák

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Natálie ProcházkováDepartment of Physiology, Second Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague, Czech Republic.
Carl Václav Lím OlsonDepartment of Physiology, Second Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague, Czech Republic.
Niki ShariatiDepartment of Physiology, Second Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague, Czech Republic.
Jana Thao RozlivkováDepartment of Physiology, Second Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague, Czech Republic.
Jana PopulováDepartment of Physiology, Second Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague, Czech Republic.
Monika ŘehořováDepartment of Physiology, Second Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague, Czech Republic.
Jan KudláčekDepartment of Physiology, Second Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague, Czech Republic.
Přemysl Jiruška *Department of Physiology, Second Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague, Czech Republic.
Ondřej Novák *Department of Physiology, Second Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague, Czech Republic. ondrej.novak@lfmotol.cuni.cz.

Funding

Ministerstvo Školství, Mládeže a Tělovýchovy ERDF project Brain Dynamics (CZ.02.01.01/00/22_008/0004643)Ministerstvo Školství, Mládeže a Tělovýchovy EU - Next Generation EU: LX22NPO5107Ministerstvo Zdravotnictví Ceské Republiky NW24-04-00041Ministerstvo Zdravotnictví Ceské Republiky NW24-08-00394Univerzita Karlova v Praze EXCITE (UNCE24/MED/021)Univerzita Karlova v Praze PRIMUS/23/MED/011
6 · The paper itself

Abstract

Focal cortical dysplasia (FCD) is a common malformation of cortical development and a major cause of early-onset, drug-resistant epilepsy. FCD type II is defined by abnormal lamination, altered cellular composition, and pathological cells, notably dysmorphic neurons (DNs) and balloon cells. DNs are thought to drive epileptogenicity through both cell-autonomous and non-cell-autonomous mechanisms, the latter including not only aberrant connectivity but also indirect modulation of excitability in local cell populations. We performed a multiscale structural and morphological analysis to elucidate the basis of FCD epileptogenicity and the impact of somatic mTOR mutations during brain development. Using a mouse model of FCD type II, we show that lesions in frontal and motor cortical regions are the strongest predictors of spontaneous seizure occurrence. This localization-dependent epileptogenicity offers an experimental explanation for the higher clinical epileptogenicity of frontal FCDs and suggests that posterior lesions may remain silent-an open question in human pathology. In our model, FCD tissue displayed considerable expansion, with cortical thickness up to ~ 20% in seizure-bearing animals. This expansion coincided with an overall ~ 40% reduction in neuronal density, consistent with tissue hypertrophy. DN density did not differ between seizure and non-seizure animals, challenging the notion that higher DN load directly predicts epileptogenesis. At the microscopic level, we describe DN axonal pathologies, including giant varicosities. In the cortex, these appeared as vesicle-filled boutons, whereas along callosal axons they were frequent but largely empty. Bouton density was markedly reduced in FCD cortex. Together, these findings leave the net synaptic effect of dysmorphic neurons unresolved, challenging the assumption that axonal hypertrophy translates into increased excitatory drive. While morphological abnormalities in FCD type II are well documented, their functional consequences remain incompletely understood. Here, we used macro- and microscopic structural features of FCDII to assess seizure susceptibility, providing new insights into epileptogenesis.

Indexed as

BrainMalformations of Cortical Development, Group ISeizuresAnimalsDisease Models, AnimalEpilepsyFemaleMaleMiceMice, Inbred C57BLMice, TransgenicNeuronsTOR Serine-Threonine KinasesmTOR protein, mouseTOR Serine-Threonine KinasesAxonal varicositiesCytoarchitectureFocal cortical dysplasia type IILesion topographyParvalbumin interneuronsPredictive parametersSomatostatin interneurons

Identifiers

PMID41366489
PMCPMC12690940

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.